RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: R37CA259260
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Grant: R35 CA304457
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Grant: R01 CA283364
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Grant: R01 CA242020
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Grant: R01 HL128239
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Grant: P50 CA254838-01
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Grant: R01 CA251138
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: K08 CA218901
NCI NIH HHS
Grant: P50 CA254838
NCI NIH HHS
Grant: R01 CA201247
Cycle for Survival
American Society of Hematology
West Family Foundation
Applebaum Foundation
Edward P. Evans Foundation
National Cancer Center
National Institutes of Health
MeSH Terms
Keywords